Skip to content
Parker Institute for Cancer Immunotherapy
Search Close

Anna Ralser, MD, PhD

Parker Scholar


Anna Ralser, MD, PhD, is a postdoc in the lab of Karin Pelka, PhD, at Gladstone Institutes. Dr. Ralser’s focus is on spatially organized multicellular interaction networks between immune and malignant cells that were recently discovered in human colorectal cancer by Dr. Pelka and others. Dr. Ralser aims to improve responsiveness to cancer immunotherapy by elucidating mechanisms accounting for the spatio-temporal coordination between those cellular hubs by combining high-plex in situ hybridization with CRISPR-based perturbation studies and innovative computational approaches under co-mentorship of Barbara Engelhardt, PhD. During her MD/PhD studies at the Technical University of Munich, Dr. Ralser investigated the interplay of cellular compartments in H. pylori-driven CRC using cutting-edge technologies such as scRNAseq and in-depth histologic monitoring of cellular phenotypes in their local environment.

View Dr. Ralser’s YouTube Short.

Education & Training

  • 2023-Present: Postdoctoral Researcher, Gladstone-UCSF Institute of Genomic Immunology, San Francisco
  • 2022: MD and PhD, Technical University of Munich, Germany
  • 2017: Medical Degree, Medical University of Innsbruck, Austria

Awards & Honors

  • 2023: Parker Scholar